palliative benefits of the multimodality approach in the re-treatment of recurrent malignant glioma: two case reports
Abstract
Two young male patients treated seven and four years back, for malignant glioma, returned with recurrence at the same site, with a World Health Organization (WHO) Performance Score of four and two. Both underwent resurgery and received postoperative reirradiation of 5040 cGy in 28 fractions and concurrent Temozolomide 75 mg/m 2 body surface area (BSA) daily, and one patient received additional adjuvant Temozolomide 250 mg (150 mg/m 2 BSA). Both patients tolerated the treatment well with 16 and 14 months follow-up from the time of recurrence. They were symptom-free, with normal physical function and good mental state, and resumed their respective jobs.
Keywords
Cancer
Iran
Breast cancer
awareness
quality of life
hiv/aids
death
palliative care
oral cancer
prescribing practices
oncology nurses
radiation
rural areas
head and neck cancer
ptosis
radiculopathy
nurses
cancer pain
lived experience
comparative study
doctors
pregabalin
mucositis
urban areas
pain relief
Citation
ID:
181965
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
181965
Unique Identifier:
10.4103/0973-1075.58464
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
